TUMOR MICROENVIRONMENT GROUP (PI VOOIJS)

INTO-PROT: Increasing therapeutic window of proton therapy in brain, head and neck cancer

Period: 2019-2023

C-PI workpackage leader: Prof. Marc Vooijs

Sum: 1,6m€

Sum to person: 1,0 FTE Researcher + benchfee

Funded by: KWF

Marie-Curie International Training Network (ITN) THERADNET, 14 PhD

Period: 2019-2022

Project Coordinator: University of Zurich, (Co-PI)

Other participants: Maastricht, Leuven, Dresden, Paris, Essen, Zurich, Oxford

Sum:  4,300 K

Sum to person: 1 PhD - UM

Funded by: EU

Glioma organoids as patient avatars to improve precision medicine

Grant #  UM 2018-11698

period 2018-2020

Project Coordinator: Prof. Marc Vooijs

Sum : 150 K€

Funded by: KWF/ Unieke Kansen , Hoog Risico Alpe d'Huzes

 

Can lipid lowering drugs improve treatment response in Glioblastoma

Grant #  UM 2015-2018

period 2016-2018

Project Coordinator: Prof. Marc Vooijs

Sum : 150 K€

Funded by: KWF/ Unieke Kansen , Hoog Risico Alpe d'Huzes

RADIATE: Radiation Innovations for Therapy and Education
Grant:# 642623

Period: 2015-2018

Project coordinator: University of Oxford , UK

Other participants: Maastricht, Leuven, Dresden, Paris, Essen, Zurich

Sum of contract in Euro’s: 3500 K

Sum to person; 14 PhD

Funded by: H2020 Marie-Curie International Training Network (ITN)

Targeting Notch/g-secretase to enhance standard treatment for non-small cell lung cancer 

Grant# 13-1197

Period: 2013-2016

Project coordinator: Prof. Marc Vooijs

Sum awarded: 280 K€

Funded by: World Wide Cancer Research (formerly AICR)

 

Capitalizing on Notch Biomarkers (CapNOTCH)

Grant # 334987

Period: 2013-2014

Project coordinator: Prof. Marc Vooijs

Sum awarded: 150 K€

Funded by: ERC PoC (Proof of Concept)

 

Disabling radiation resistance in Cancer treatment (DIRECT)

Grant # 617060

Period: 2013-2018

Project coordinator: Prof. Marc Vooijs

Sum awarded: 1,85 M€

Funded by: ERC-Consolidator grant

 

Targeting the Notch protease interface (NOTCH PROTEOLYSIS)

Grant # 208259

Period 2008-2014

Project coordinator: Prof Marc Vooijs

Sum awarded: 1,2 M€

Funded: ERc Starting grant (ERC-Stg)

 

AUTOPHAGY GROUP (PI ROUSCHOP)

 

Extracellulaire vesicles als therapeutisch target ter verbetering van glioblastoom-therapie –deel 1

Period: 2020

Project coordinator: Kasper Rouschop

Funded by: Zeldzame Ziekten Fonds/rare diseases fund

Sum of contract in Euro’s: € 60.000

 

Elevating autophagy-dependence of hypoxic Glioblastoma cells for increased therapeutic benefit

Period: 2020-2024

Project coordinator: Kasper Rouschop

Other participants: Bradly Wouters (UM/UHN Toronto Canada)

Funded by: KWF

Sum awarded: € 498.500

Autophagy associated extracellular vesicles in glioblastoma multiforme: new players in hypoxia-associated tumour progression?

Period: 2016-2019

project coordinator: Dr. Kasper Rouschop

Funded by: Worldwide Cancer Research (formerly AICR)

Sum of contract in Euro’s: € 295.000

 

Hypoxia associated exosomes: a new target in hypoxia-associated tumour aggressiveness? 

Period: 2015-2019

project coordinator: Dr. Kasper Rouschop

Funded by: KWF project grant

Sum of contract in Euro’s: € 563.100

 

GABARAPL1 associated exosomes: a new target in hypoxia-associated tumour aggressiveness?.

# UM2015-7735 

period:2015-2019

project coordinator: Dr. Kasper Rouschop

Funded by: KWF

 

Hypoxia-induced autophagy: a therapeutic target for cancer therapy?

# UM 2010-4714

Period: 2010-2014 

Project coordinator: Dr. Kasper Rouschop 

Funded by: KWF 

 

Autophagy signaling, an essential requirement for tumor microenvironment maintenance and therefore a therapeutic target

#UM 2012-5506

Project coordinator: Dr. Kasper Rouschop 

Period: 2012-2018 

Funded by: KWF

Copyright © 2020 | Maastricht Radiation Oncology Lab Maastricht University / MUMC

  • Google Places Social Icon
  • Facebook Social Icon
  • Twitter Social Icon